Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial.

IF 7.8 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Circulation: Heart Failure Pub Date : 2024-07-01 Epub Date: 2024-06-12 DOI:10.1161/CIRCHEARTFAILURE.123.011393

Carmine G De Pasquale, Brian Claggett, Karola Jering, John J V McMurray, Douglas Mann, Zi Michael Miao, Christopher B Granger, Lars Køber, Aldo P Maggioni, Jean-Lucien Rouleau, Scott D Solomon, Philippe Gabriel Steg, Peter van der Meer, Eugene Braunwald, Marc A Pfeffer

引用次数: 0

查看原文本刊更多论文

高风险急性心肌梗死患者开始使用血管紧张素受体-奈普利酶抑制剂的安全性和耐受性与护理环境的关系：PARADISE-MI 试验的分组分析。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Circulation: Heart Failure 医学-心血管系统

CiteScore

12.90

自引率

3.10%

发文量

271

审稿时长

6-12 weeks

期刊介绍： Circulation: Heart Failure focuses on content related to heart failure, mechanical circulatory support, and heart transplant science and medicine. It considers studies conducted in humans or analyses of human data, as well as preclinical studies with direct clinical correlation or relevance. While primarily a clinical journal, it may publish novel basic and preclinical studies that significantly advance the field of heart failure.